ebola?
Bluelight Crew
okay...check out this:
Title:
Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain?
European Journal of Neuroscience. Vol 18(12) Dec 2003, 3394-3399.
Blackwell Publishing, United Kingdom
Abstract
Stimulant drugs such as amphetamine have, for many decades, been the drugs of choice in the treatment of children with attention-deficit/hyperactivity disorder. In the present study we investigated whether repeated exposure of a low dose of amphetamine to juvenile rats could induce long-term morphological alterations in the prefrontal cortex. In addition, to assess possible behavioural consequences of prolonged exposure to this drug, we examined whether changes in the motor response to various dopamine agonists occurred after this treatment. We found that this dose of amphetamine promotes plasma concentrations of amphetamine sulphate in juvenile rats to levels corresponding to the clinical range used for children with attention-deficit/hyperactivity disorder. This treatment produced an increase in dendritic length and branches of pyramidal neurons of the medial prefrontal cortex, but not in the nucleus accumbens. Interestingly, amphetamine pre-treatment did not alter the motor response to various dopamine agonists, including amphetamine. These data suggest that clinical doses of stimulant drugs may be acting as a trophic support at the glutamatergic synapses, thereby enhancing dopamine-glutamate interactions in the prefrontal cortex. (PsycINFO Database Record (c) 2004 APA, all rights reserved)
Any speculations on the ramifications of these types of changes in humans? Also, pertinent meta-analyses I've seen have argued that stims. tend to lose their efficacy (and have overall negative effects) for ADD after a matter of years, but are still quite effective in the window of 24 months of a typical daily regimen.
ebola
Title:
Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain?
European Journal of Neuroscience. Vol 18(12) Dec 2003, 3394-3399.
Blackwell Publishing, United Kingdom
Abstract
Stimulant drugs such as amphetamine have, for many decades, been the drugs of choice in the treatment of children with attention-deficit/hyperactivity disorder. In the present study we investigated whether repeated exposure of a low dose of amphetamine to juvenile rats could induce long-term morphological alterations in the prefrontal cortex. In addition, to assess possible behavioural consequences of prolonged exposure to this drug, we examined whether changes in the motor response to various dopamine agonists occurred after this treatment. We found that this dose of amphetamine promotes plasma concentrations of amphetamine sulphate in juvenile rats to levels corresponding to the clinical range used for children with attention-deficit/hyperactivity disorder. This treatment produced an increase in dendritic length and branches of pyramidal neurons of the medial prefrontal cortex, but not in the nucleus accumbens. Interestingly, amphetamine pre-treatment did not alter the motor response to various dopamine agonists, including amphetamine. These data suggest that clinical doses of stimulant drugs may be acting as a trophic support at the glutamatergic synapses, thereby enhancing dopamine-glutamate interactions in the prefrontal cortex. (PsycINFO Database Record (c) 2004 APA, all rights reserved)
Any speculations on the ramifications of these types of changes in humans? Also, pertinent meta-analyses I've seen have argued that stims. tend to lose their efficacy (and have overall negative effects) for ADD after a matter of years, but are still quite effective in the window of 24 months of a typical daily regimen.
ebola